|
Study source | Database | /ratio male | Age (mean ± std.) | AHI (mean ± std.) | Reference test | Event definition | AHI cut-off | Sensitivity (%) | Specificity (%) | Others | Validation |
|
Daniels et al. [17] | Birmingham Heartlands Hospital, UK | 21/— | — | — | Retrospective clinical diagnosis | — | — | 100 | 66 | PPV = 0.95 NPV = 1.00 | S |
|
Lévy et al. [18] | CHU de Grenoble, France | 301/— | 56 ± 12 | 30 ± 24 | Same-night Level 1 PSG | H: >50% reduction + [3% desaturation or arousal] | 15 | 90 | 75 | PPV = 0.87 NPV = 0.81 | S |
|
Olson et al. [19] | Newcastle Sleep Disorders Center, Australia | 793/— | — | — | Same-night Level 1 PSG | — | 5 | 82.7 | 54.2 | — | S |
|
Magalang et al. [20] | Associated Sleep Center and the Buffalo Veterans Affairs Medical Center, USA | 224/— (TR) 101/— (TS1) 191/— (TS2) | 48.9 ± 12.3 (TR) 51.8 ± 11.5 (TS1) 56.0 ± 12.8 (TS2) | 18.2 ± 20.0 (TR) 20.2 ± 19.5 (TS1) 18.2 ± 21.2 (TS2) | Same-night Level 1 PSG | H: discernible reduction + [4% desaturation or arousal] | 15 | 90 (TR) — (TS1) — (TS2) | 70 (TR) — (TS1) — (TS2) | — | TR/TS1/TS2 |
|
Zamarrón et al. [21] | Hospital General de Galicia, Spain | 233/0.80 | 56.8 ± 13.1 (OSA) 56.1 ± 13.0 (Non-OSA) | 40.1 ± 23.0 (OSA) 2.2 ± 2.7 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + 4% desaturation | 10 | 78 | 89 | PPV = 0.89 NPV = 0.78 | S |
|
Zamarrón et al. [22] | Hospital General de Galicia, Spain | 300/0.78 | 58.4 ± 12.1 (OSA) 56.6 ± 12.8 (Non-OSA) | 40.2 ± 22.4 (OSA) 2.3 ± 2.7 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + 4% desaturation | 10 | 94 | 82 | PPV = 0.87 NPV = 0.92 | S |
|
Hua and Yu [23] | Chang Gung Memorial Hospital, China | 273/0.77 (TR) 206/0.81 (TS) | 45.8 ± 16.5 (TR) 46.2 ± 13.4 (TS) | 31.6 ± 27.1 (TR) 44.1 ± 29.8 (TS) | Same-night Level 1 PSG | AASM1999 H: >50% reduction or <50% reduction + [3% desaturation or arousal] | 5 | — | — | AUC = 0.96 | TR/TS |
|
Morillo et al. [24] | University Hospital Puerta del Mar de Cadiz, Spain | 37/0.78 (TR) 78/0.74 (TS) | 57.9 ± 9.8 (TR) 58.3 ± 12.5 (TS) | 32.6 ± 29.24 (TR) 28.8 ± 28.3 (TS) | Same-night Level 1 PSG | H: >50% reduction + 4% desaturation | 20 | 86.4 | 82.8 | AUC = 0.92 ICC = 0.82 | TR/TS |
|
Álvarez et al. [25, 26] | Hospital Clinico Universitario in Santiago de Compostela, Spain | 111/0.85 (OSA) 76/0.70 (Non-OSA) | 58.3 ± 12.9 (OSA) 57.6 ± 12.9 (Non-OSA) | 40.1 ± 19.6 (OSA) 2.04 ± 2.36 (Non-OSA) | Same-night Level 1 PSG | H: reduction (no cessation) + 4% desaturation | 10 | 90.1 | 82.9 | AUC = 0.92 ACC = 0.87 | S |
|
Hornero et al. [27] | Hospital Clinico Universitario in Santiago de Compostela, Spain | 111/0.85 (OSA) 76/0.70 (Non-OSA) | 58.3 ± 12.9 (OSA) 57.6 ± 12.9 (Non-OSA) | 40.1 ± 19.6 (OSA) 2.04 ± 2.36 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + 4% desaturation | 10 | 82.1 | 87 | — | TR/TS (113) |
|
del Campo et al. [28] | Hospital Clinico Universitario in Santiago de Compostela, Spain | 111/0.85 (OSA) 76/0.70 (Non-OSA) | 58.3 ± 12.9 (OSA) 57.6 ± 12.9 (Non-OSA) | 40.1 ± 19.6 (OSA) 2.03 ± 2.19 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + 3% desaturation | 10 | 88.3 | 82.9 | AUC = 0.92 PPV = 0.88 NPV = 0.83 | S |
|
Marcos et al. [29] | Hospital Clinico Universitario in Santiago de Compostela, Spain | 111/0.85 (OSA) 76/0.70 (Non-OSA) | 58.3 ± 12.9 (OSA) 57.6 ± 12.9 (Non-OSA) | 40.1 ± 19.6 (OSA) 2.04 ± 2.36 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + 4% desaturation | 10 | 79.1 | 97.8 | AUC = 0.92 ACC = 0.87 | TR/TS (113) |
|
Victor-Marcos et al. [30] | Hospital Universitario Pío del Río Hortega, Spain | 166/0.84 (OSA) 48/0.67 (Non-OSA) | 55 ± 13.5 (OSA) 47.7 ± 9.76 (Non-OSA) | 37.1 ± 25.8 (OSA) 4.13 ± 2.39 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + 4% desaturation | 10 | 97.0 | 79.3 | AUC = 0.95 ACC = 0.93 | TR/TS (129) |
|
Álvarez et al. [34] | Hospital Universitario Pío del Rio Hortega, Spain | 100/0.84 (OSA) 48/0.67 (Non-OSA) | 55.2 ± 14.6 (OSA) 48.3 ± 11.8 (Non-OSA) | 40.9 ± 27.6 (OSA) 4.1 ± 2.4 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + [3% desaturation or arousal] | 10 | 92 | 85.4 | AUC = 0.97 ACC = 0.90 | CV (Leave-one-out) |
|
Álvarez et al. [35] | Hospital Universitario Pío del Rio Hortega, Spain | 160/0.84 (OSA) 80/0.65 (Non-OSA) | 54.8 ± 13.8 (OSA) 47.2 ± 12.2 (Non-OSA) | 36.6 ± 25.7 (OSA) 3.9 ± 2.4 (Non-OSA) | Same-night Level 1 PSG | AASM2007 H: >50% reduction + [3% desaturation or arousal] | 10 | 90.6 | 81.3 | ACC = 0.87 | TR/TS (144) |
|
El-Solh et al. [36] | Veterans Affairs Medical Center, USA | 213/— | — | — | Same-night Level 1 PSG | H: discernible reduction + [3% desaturation or arousal] | 5 (OSA) 10 (CSR-CSA) | 97.7 (OSA) 100 (CSR-CSA) | 100 (OSA) 99 (CSR-CSA) | ACC = 0.99 (OSA, CSR-CSA) | CV (5 K-fold) |
|
Marcos et al. [31] | Hospital Clinico Universitario in Santiago de Compostela, Spain | 111/0.85 (OSA) 76/0.70 (Non-OSA) | 58.3 ± 12.9 (OSA) 57.6 ± 12.9 (Non-OSA) | 40.1 ± 19.6 (OSA) 2.04 ± 2.36 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + 4% desaturation | 10 | 89.4 ± 1.6 | 81.4 ± 1.7 | AUC = 0.91 ACC = 0.86 | TR/TS1 (30)/TS2 (83) |
|
Victor-Marcos et al. [32] | Hospital Clinico Universitario in Santiago de Compostela, Spain | 111/0.85 (OSA) 76/0.70 (Non-OSA) | 58.3 ± 12.9 (OSA) 57.6 ± 12.9 (Non-OSA) | 40.1 ± 19.6 (OSA) 2.04 ± 2.36 (Non-OSA) | Same-night Level 1 PSG | H: >50% reduction + 4% desaturation | 10 | 90.8 ± 4.2 | 79.1 ± 6.9 | AUC = 0.91 ACC = 0.86 | TR/TS1 (30)/TS2 (83) |
|
Victor-Marcos et al. [33] | Hospital Universitario Pío del Rio Hortega, Spain | 240/0.77 | 52.3 ± 13.8 (TR) 52.2 ± 13.7 (TS) | 24.7 ± 25.2 (TR) 26.4 ± 26.7 (TS) | Same-night Level 1 PSG | — | 15 | 94.9 | 90.9 | ACC = 0.93 ICC = 0.91 | TR/TS (144) |
|
Gutierrez-Tobal et al. [37] | Hospital Universitario Pío del Rio Hortega, Spain | 148/0.79 | 50.9 ± 11.7 | 23.5 ± 24.1 | Same-night Level 1 PSG | H: >30% reduction + 4% desaturation | 30 | 76.7 | 93.2 | ACC = 0.88 | TR/TS (89) |
|
Gutiérrez-Tobal et al. [38] | Hospital Universitario Pío del Rio Hortega, Spain | 148/0.79 | 50.9 ± 11.7 | 23.5 ± 24.1 | Same-night Level 1 PSG | H: >30% reduction + 4% desaturation | 10 | 88 | 70.8 | AUC = 0.90 ACC = 0.82 | CV (Leave-one-out) |
|
Caseiro et al. [39] | Coimbra Sleep Disorders Clinic, Portugal | 21/0.52 (OSA) 20/0.35 (Non-OSA) | 59.9 ± 13.9 (OSA) 40.8 ± 12 (Non-OSA) | 47.4 ± 32.8 (OSA) 2.17 ± 1.56 (Non-OSA) | Same-night Level 1 PSG | — | 5 | 81 | 95 | AUC = 0.88 | S |
|
Salisbury and Sun [40] | Vanguard Technologies | 18/— (TR1) 16/— (TR2) | — | — (TR1) 33.2 ± 35.7 (TR2) | Retrospective clinical diagnosis (TR1) Different-night Level 1 PSG (TR2) | H: >50% reduction + 5% desaturation | 5 | 100 (TR1) 85.7 (TR2) | 100 (TR1) 100 (TR2) | = 0.30 | S |
|